vs
Side-by-side financial comparison of AerSale Corp (ASLE) and NovoCure Ltd (NVCR). Click either name above to swap in a different company.
NovoCure Ltd is the larger business by last-quarter revenue ($174.1M vs $90.9M, roughly 1.9× AerSale Corp). AerSale Corp runs the higher net margin — 5.9% vs -40.9%, a 46.8% gap on every dollar of revenue. On growth, NovoCure Ltd posted the faster year-over-year revenue change (12.3% vs -4.0%). Over the past eight quarters, NovoCure Ltd's revenue compounded faster (7.6% CAGR vs 0.2%).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
NovoCure Ltd is a global oncology company that develops and commercializes innovative Tumor Treating Fields (TTFields) therapy, a non-invasive wearable treatment using low-intensity electric fields to disrupt cancer cell division. Its approved therapies target glioblastoma, malignant mesothelioma and non-small cell lung cancer, serving patients across North America, Europe and Asia Pacific.
ASLE vs NVCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $90.9M | $174.1M |
| Net Profit | $5.4M | $-71.1M |
| Gross Margin | 34.1% | 77.6% |
| Operating Margin | 7.8% | — |
| Net Margin | 5.9% | -40.9% |
| Revenue YoY | -4.0% | 12.3% |
| Net Profit YoY | 99.7% | -107.3% |
| EPS (diluted) | $0.10 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $174.1M | ||
| Q4 25 | $90.9M | $174.3M | ||
| Q3 25 | $71.2M | $167.2M | ||
| Q2 25 | $107.4M | $158.8M | ||
| Q1 25 | $65.8M | $155.0M | ||
| Q4 24 | $94.7M | $161.3M | ||
| Q3 24 | $82.7M | $155.1M | ||
| Q2 24 | $77.1M | $150.4M |
| Q1 26 | — | $-71.1M | ||
| Q4 25 | $5.4M | $-24.5M | ||
| Q3 25 | $-120.0K | $-37.3M | ||
| Q2 25 | $8.6M | $-40.1M | ||
| Q1 25 | $-5.3M | $-34.3M | ||
| Q4 24 | $2.7M | $-65.9M | ||
| Q3 24 | $509.0K | $-30.6M | ||
| Q2 24 | $-3.6M | $-33.4M |
| Q1 26 | — | 77.6% | ||
| Q4 25 | 34.1% | 75.8% | ||
| Q3 25 | 30.2% | 73.2% | ||
| Q2 25 | 32.9% | 73.9% | ||
| Q1 25 | 27.3% | 75.1% | ||
| Q4 24 | 31.4% | 79.2% | ||
| Q3 24 | 28.6% | 77.2% | ||
| Q2 24 | 28.2% | 77.0% |
| Q1 26 | — | — | ||
| Q4 25 | 7.8% | -23.2% | ||
| Q3 25 | 4.0% | -21.5% | ||
| Q2 25 | 11.7% | -24.9% | ||
| Q1 25 | -10.1% | -24.4% | ||
| Q4 24 | 5.2% | -39.3% | ||
| Q3 24 | 2.4% | -20.7% | ||
| Q2 24 | -2.4% | -22.3% |
| Q1 26 | — | -40.9% | ||
| Q4 25 | 5.9% | -14.1% | ||
| Q3 25 | -0.2% | -22.3% | ||
| Q2 25 | 8.0% | -25.3% | ||
| Q1 25 | -8.0% | -22.1% | ||
| Q4 24 | 2.9% | -40.9% | ||
| Q3 24 | 0.6% | -19.7% | ||
| Q2 24 | -4.7% | -22.2% |
| Q1 26 | — | — | ||
| Q4 25 | $0.10 | $-0.22 | ||
| Q3 25 | $0.00 | $-0.33 | ||
| Q2 25 | $0.18 | $-0.36 | ||
| Q1 25 | $-0.10 | $-0.31 | ||
| Q4 24 | $0.05 | $-0.61 | ||
| Q3 24 | $0.01 | $-0.28 | ||
| Q2 24 | $-0.07 | $-0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $432.0M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $424.4M | $330.7M |
| Total Assets | $640.5M | $787.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $432.0M | ||
| Q4 25 | $4.4M | $93.5M | ||
| Q3 25 | $5.3M | $342.1M | ||
| Q2 25 | $5.7M | $149.6M | ||
| Q1 25 | $4.7M | $127.3M | ||
| Q4 24 | $4.7M | $163.8M | ||
| Q3 24 | $9.8M | $185.4M | ||
| Q2 24 | $4.3M | $164.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — |
| Q1 26 | — | $330.7M | ||
| Q4 25 | $424.4M | $340.5M | ||
| Q3 25 | $417.1M | $341.3M | ||
| Q2 25 | $415.9M | $349.4M | ||
| Q1 25 | $406.5M | $362.0M | ||
| Q4 24 | $455.6M | $360.2M | ||
| Q3 24 | $451.5M | $360.8M | ||
| Q2 24 | $449.8M | $361.8M |
| Q1 26 | — | $787.9M | ||
| Q4 25 | $640.5M | $804.3M | ||
| Q3 25 | $646.3M | $1.4B | ||
| Q2 25 | $646.7M | $1.2B | ||
| Q1 25 | $646.1M | $1.2B | ||
| Q4 24 | $604.7M | $1.2B | ||
| Q3 24 | $601.5M | $1.2B | ||
| Q2 24 | $598.7M | $1.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | — |
| Free Cash FlowOCF − Capex | $9.8M | — |
| FCF MarginFCF / Revenue | 10.8% | — |
| Capex IntensityCapex / Revenue | 1.7% | — |
| Cash ConversionOCF / Net Profit | 2.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.4M | $-18.0M | ||
| Q3 25 | $-8.9M | $20.6M | ||
| Q2 25 | $19.8M | $-15.9M | ||
| Q1 25 | $-45.2M | $-35.7M | ||
| Q4 24 | $37.5M | $-3.5M | ||
| Q3 24 | $10.4M | $10.4M | ||
| Q2 24 | $-15.3M | $-1.7M |
| Q1 26 | — | — | ||
| Q4 25 | $9.8M | $-22.9M | ||
| Q3 25 | $-9.8M | $14.9M | ||
| Q2 25 | $18.6M | $-21.4M | ||
| Q1 25 | $-47.6M | $-46.3M | ||
| Q4 24 | $32.3M | $-12.4M | ||
| Q3 24 | $8.9M | $-307.0K | ||
| Q2 24 | $-18.9M | $-13.2M |
| Q1 26 | — | — | ||
| Q4 25 | 10.8% | -13.1% | ||
| Q3 25 | -13.8% | 8.9% | ||
| Q2 25 | 17.3% | -13.5% | ||
| Q1 25 | -72.4% | -29.9% | ||
| Q4 24 | 34.0% | -7.7% | ||
| Q3 24 | 10.7% | -0.2% | ||
| Q2 24 | -24.6% | -8.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.7% | 2.8% | ||
| Q3 25 | 1.3% | 3.4% | ||
| Q2 25 | 1.1% | 3.5% | ||
| Q1 25 | 3.7% | 6.8% | ||
| Q4 24 | 5.6% | 5.5% | ||
| Q3 24 | 1.9% | 6.9% | ||
| Q2 24 | 4.7% | 7.6% |
| Q1 26 | — | — | ||
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
NVCR
Segment breakdown not available.